EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Effect of residual kidney function and dialysis adequacy on chronic pruritus in dialysis patients

Robin Lengton iD, Esmee M van der Willik iD, Esther N M de Rooij iD, Yvette Meuleman iD, Saskia Le Cessie iD, Wieneke M Michels iD, Marc Hemmelder iD, Friedo W Dekker iD, Ellen K Hoogeveen iD, Netherlands Cooperative Study on the Adequacy of Dialysis-2 (NECOSAD) Study Group

Nephrology Dialysis Transplantation · 2023

DOI: 10.1093/ndt/gfac341 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, 2023. Verfasst von Robin Lengton und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Epidemiology, Leiden University Medical Centre, Leiden, The Netherlands. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Kidney Failure, Chronic. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Dutch Kidney Foundation, Dutch National Health Insurance Board, Vifor Pharma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic kidney disease–associated pruritus (CKD-aP) is common in dialysis patients, and is associated with lower quality of life and increased risk of death. We investigated the association between residual estimated glomerular filtration rate (eGFR), dialysis adequacy or serum phosphate level and CKD-aP in incident dialysis patients.

Methods

A total of 1256 incident hemodialysis (HD) and 670 peritoneal dialysis (PD) patients (>18 years) from the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD) study were included (1997–2007) and followed until death, transplantation or a maximum of 10 years. CKD-aP was measured using a single item of the Kidney Disease Quality of Life Instrument-36. The associations were studied by logistic and linear regression analyses, adjusted for potential baseline confounders.

Results

At baseline mean (standard deviation) age was 60 (16) years, 62% were men and median (interquartile range) residual eGFR was 3.4 (1.7; 5.3) mL/min/1.73 m2. The prevalence of CKD-aP (∼70%) was similar in HD and PD. It was observed that 12 months after starting dialysis (after multivariable adjustment) each 1 mL/min/1.73 m2 higher residual eGFR, one unit higher total weekly Kt/V, or 1 mmol/L lower serum phosphate level was associated with lower burden of CKD-aP in HD and PD patients of –0.05 (95% CI –0.09; –0.02) and –0.09 (95% CI –0.13; –0.05), –0.15 (95% CI –0.26; –0.05) and –0.35 (95% CI –0.54; –0.16), and of –0.34 (95%CI: –0.51; –0.17) and –0.45 (95%CI: –0.71; –0.19), respectively. We found no association between dialysis Kt/V and CKD-aP.

Conclusions

Higher residual eGFR and lower serum phosphate level, but not the dialysis dose, were related with lower burden of CKD-aP in dialysis patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicKidney Failure, ChronicMaleHumansMiddle AgedFemaleRenal DialysisQuality of LifeKidneyPruritusPhosphates

Stichwörter der Autor:innen

dialysisdialysis adequacyitchingpruritusresidual kidney function

Substanzen

Phosphates

Autor:innen und Institutionen

  • Department of Clinical Epidemiology, Leiden University Medical Centre, Leiden, The Netherlands.
  • Department of Nephrology, Leiden University Medical Centre, Leiden, The Netherlands.
  • Section Medical Statistics, Department of Biomedical Datasciences, Leiden University Medical Centre, Leiden, The Netherlands.
  • Department of Internal Medicine, Division of Nephrology, Maastricht University Medical Centre and CARIM Research School for Cardiovascular Disease, Maastricht, The Netherlands.
  • Department of Nephrology, Jeroen Bosch Hospital, den Bosch, The Netherlands.

ORCID-Profile: Robin Lengton, Esmee M van der Willik, Esther N M de Rooij, Yvette Meuleman, Saskia Le Cessie, Wieneke M Michels, Marc Hemmelder, Friedo W Dekker, Ellen K Hoogeveen

Förderung

  • Dutch Kidney Foundation
  • Dutch National Health Insurance Board
  • Vifor Pharma

Zitieren

APA

Lengton, R., van der Willik, E. M., de Rooij, E. N. M., Meuleman, Y., Le Cessie, S., Michels, W. M., Hemmelder, M., Dekker, F. W., Hoogeveen, E. K., & Netherlands Cooperative Study on the Adequacy of Dialysis-2 (NECOSAD) Study Group (2023). Effect of residual kidney function and dialysis adequacy on chronic pruritus in dialysis patients. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfac341

Vancouver

Lengton R, van der Willik EM, de Rooij ENM, Meuleman Y, Le Cessie S, Michels WM, et al. Effect of residual kidney function and dialysis adequacy on chronic pruritus in dialysis patients. Nephrology Dialysis Transplantation. 2023. doi:10.1093/ndt/gfac341

BibTeX
@article{Lengton2023,
  author = {Lengton, Robin and van der Willik, Esmee M and de Rooij, Esther N M and Meuleman, Yvette and Le Cessie, Saskia and Michels, Wieneke M and Hemmelder, Marc and Dekker, Friedo W and Hoogeveen, Ellen K and Netherlands Cooperative Study on the Adequacy of Dialysis-2 (NECOSAD) Study Group, Netherlands Cooperative Study on the Adequacy of Dialysis-2 (NECOSAD) Study Group},
  title = {Effect of residual kidney function and dialysis adequacy on chronic pruritus in dialysis patients},
  journal = {Nephrology Dialysis Transplantation},
  year = {2023},
  doi = {10.1093/ndt/gfac341}
}
Kostenlos starten →